| Health / Medical Topics |
Cholecystokinin B Receptor Antagonist YF476
An orally active, benzodiazepine type, selective cholecystokinin B receptor (CCKBR; CCK2R; gastrin receptor) antagonist with potential gastric acid reducing and antiproliferative activity. Upon administration of YF476, this agent selectively binds to and blocks the CCKBR, thereby preventing the binding of gastrin and cholecystokinin. This may prevent gastric neuroendocrine enterochromaffin-like (ECL) cell-induced secretion of histamine, ultimately preventing gastric acid secretion from adjacent parietal cells. In addition, YF476 may inhibit ECL cell proliferation and ECL-derived gastric carcinoids. (NCI Thesaurus)
YOU MAY ALSO LIKE
An acute or chronic inflammation of the gallbladder associated with the presence of gallstones.
An acute or chronic inflammation involving the gallbladder wall. It may be associated with the presence of gallstones.
Surgical removal of the gallbladder.
A nutrient that the body needs in small amounts to function and stay healthy. Cholecalciferol helps the body use calcium and phosphorus…
An acute or chronic inflammatory process affecting the biliary tract.
A tumor of the connective tissues of the bile ducts.
